- GlobeNewswire•3 hours ago
CAMBRIDGE, Mass., Aug. 31, 2016-- Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will provide a corporate ...
- Motley Fool•7 days ago
A patent review board rules that claims on Teva Pharmaceuticals' three-times-weekly version of Copaxone aren't patentable.
Momenta Pharmaceuticals Inc. (MNTA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||11.77 x 100|
|Ask||12.79 x 100|
|Day's Range||11.81 - 12.07|
|52wk Range||7.86 - 19.70|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-7.88|
|Avg Vol (3m)||550,724|
|Dividend & Yield||N/A (N/A)|